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Abstract
Background: Understanding the role of host genetics in resistance to porcine reproductive and respiratory
syndrome virus (PRRSV) infection, and the effects of PRRS on pig health and related growth, are goals of the PRRS
Host Genetics Consortium (PHGC).
Methods: The project uses a nursery pig model to assess pig resistance/susceptibility to primary PRRSV infection.
To date, 6 groups of 200 crossbred pigs from high health farms were donated by commercial sources. After
acclimation, the pigs were infected with PRRSV in a biosecure facility and followed for 42 days post infection (dpi).
Blood samples were collected at 0, 4, 7, 10, 14, 21, 28, 35 and 42 dpi for serum and whole blood RNA gene
expression analyses; weekly weights were recorded for growth traits. All data have been entered into the PHGC
relational database. Genomic DNAs from all PHGC1-6 pigs were prepared and genotyped with the Porcine SNP60
SNPchip.
Results: Results have affirmed that all challenged pigs become PRRSV infected with peak viremia being observed
between 4-21 dpi. Multivariate statistical analyses of viral load and weight data have identified PHGC pigs in
different virus/weight categories. Sera are now being compared for factors involved in recovery from infection,
including speed of response and levels of immune cytokines. Genome-wide association studies (GWAS) are
underway to identify genes and chromosomal locations that identify PRRS resistant/susceptible pigs and pigs able
to maintain growth while infected with PRRSV.
Conclusions: Overall, the PHGC project will enable researchers to discover and verify important genotypes and
phenotypes that predict resistance/susceptibility to PRRSV infection. The availability of PHGC samples provides a
unique opportunity to continue to develop deeper phenotypes on every PRRSV infected pig.
Introduction
Porcine reproductive and respiratory syndrome virus
(PRRSV), first identified in the United States in 1987,
costs U.S. swine producers >$560 million annually [1].
PRRSV-infected pigs are susceptible to pneumonia and
growth losses; infected sows have increased rates of
abortions, stillbirths, mummifications, and give birth to
weak piglets with chronic respiratory problems. It can
take weeks, even months, for pigs to clear this RNA
virus, which evolves and adapts quickly to new environ-
mental challenges such as vaccines and medications [2].
Reports of highly virulent PRRSV variants that have
spread throughout China and into Vietnam highlight
the importance of developing effective interventions to
prevent PRRSV pathology, mortality and production
losses [3-5].
Research has indicated that there are genetic compo-
nents involved in determining how effective each pig
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will be in responding to and clearing PRRSV infection
[6-17]. As discussed during the 2010 Animal Genomics
for Animal Health International Symposium deep phe-
notypes are required for identifying the genes and path-
ways that are responsible for genetic control of PRRSV
infection responses. Large numbers of animals and a
resulting broad sample set is required to probe the
numerous parameters involved. Such an effort requires
that several entities pool their funding and scientific
resources. In the US, the PRRS Host Genetics Consor-
tium (PHGC) has been developed to coordinate a PRRS
host genetics and resistance project. The objectives for
the PHGC are to: 1) Use genotyping and phenotyping
tools to determine if there are host genes that control
resistance/susceptibility to PRRSV infection; 2) Verify
genetic variation in response to PRRSV, via improved
health, survivability and growth; and 3) Identify relative
importance of different phenotypic traits, and their her-
itability, that predict response to PRRSV infection.
Methods
PHGC Planning
A large project such as the PHGC requires careful plan-
ning and commitments from diverse groups. The PHGC
was developed at three one-day US National Pork Board
meetings (15/12/05; 23/2/06; 9/5/07) with further input
from PRRS CAP and NC229 disease researchers,
NC1037/NRSP8 genome researchers, members of the
NPB Swine Health and Animal Science Committees,
veterinarians and the American Association of Swine
Veterinarians, producers, and commercial partners
representing breeders, animal health, feed, and diagnos-
tic companies. The final plan is a result of those detailed
discussions.
Pig sources
All tests have been performed on commercial pigs from
high health farms with donation of swine genetic mate-
rials as part of the Consortium. For each trial one com-
pany was requested to provide 200 pigs at weaning from
PRRSV negative (PRRSV-), Mycoplasma hyopneumo-
niae-, and swine influenza virus- farms, and if possible
from porcine circovirus type 2 (PCV2) free farms. Pigs
could be from vaccinated sows since maternal antibody
prevents them from becoming infected with PCV2. The
source populations were crossbred commercial pigs
(Genus/PIC USA; Newsham Choice Genetics; Fast
Genetics; Genetiporc, Inc.; Genesus Genetics) with com-
plete parentage and pedigree records. Since SNP chips
are used for genotyping there was a decreased need for
extensive family structure. There was no preselection of
sires for disease traits. Pigs (~200/trial) were transported
to the biosecure Kansas State University (KSU) testing
facility at weaning. All pig experiments were initiated
after approval by KSU IACUC and IBC institutional
committees. After arrival pigs were treated with broad
spectrum antibiotics for 1 week, to prevent expression
of other organisms.
Infection and phenotypic tests
After the 7 day acclimation period, pigs were challenged
intranasally/orally with PRRSV isolate NVSL 97-7985
[18] and followed for 42 days post infection (dpi). Blood
samples are collected at -6, 0, 4, 7, 10, 14, 21, 28, 35, 42
dpi for a total of 10 bleeds. Both sera and ABI Tempus
tubes for later RNA analyses were collected at all sam-
pling times. All samples were aliquoted and stored at
KSU and BARC. Pigs were weighed weekly for growth
data. Pigs were killed at 42 dpi and tonsils collected for
viral persistence and ears for genomic DNA. If there are
pig deaths during the study, dead pigs are sent for full
workup at the KSU Diagnostic Lab.
Consortium database
The Consortium relational database http://www.animal-
genome.org/lunney/index.php is the secure data reposi-
tory for all pig data including parentage information,
location and availability of all samples collected on each
pig, results of all assays performed on each sample (phe-
notypic and genotypic information). The database
resides on computers located at Iowa State University,
which are supported by NRSP8 Bioinformatics funds.
All data collected through the project will be available
to project members prior to publication and then to
general public after original publication. Access to sam-
ples and to accumulated data stored in the secure
PHGC Database is open to members who contribute
materials or data. [Access to PHGC Database is moni-
tored by the USDA ARS maintained Cooperative
Research and Development Agreement (CRADA) Mate-
rial Transfer Agreement (MTA).]
Results and discussion
Results have affirmed that all challenged pigs become
PRRSV infected with peak viremia from 4-21 dpi (Row-
land et al., manuscript in preparation). The PHGC
results revealed the appearance of stratified subpopula-
tions of PRRS resistant/ susceptible pigs, which exhib-
ited wide variations in virus load and growth
performance; examples of such anti-viral responses are
shown in Figure 1. The greatest impact of PRRSV infec-
tion was on weight, with only about 30% of infected
pigs in the same weight class as the reference control
pigs (pigs from the same litters kept uninfected and
weighed for the same 42 days). Plotting virus load versus
average daily weight gain (ADWG) showed little correla-
tion between growth and virus load. Multivariate statis-
tical analyses of viral load and weight data have
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categorized PHGC pigs into 4 extreme categories
including the most desirable, PRRS resistant low virus/
high weight gain (Lv/Hg) pigs, the worst, PRRS suscepti-
ble high virus/ low weight gain (Hv/Lg) pigs, the PRRS
tolerant, high virus/high weight gain (Hv/Hg) pigs, and
the less thrifty, low virus/low weight gain (Lv/Lg) pigs.
This statistical categorization of pigs from each PHGC
trial provides a critical basis for selecting pigs and sam-
ples for detailed analyses of processes that control tran-
scriptional and proteomic responses to PRRSV infection,
as outlined in Table 1.
Sera are now being compared for factors involved in
recovery from infection, including speed of anti-viral
responses and levels of immune cytokines. Selected
whole blood RNA samples are being compared for gene
expression using the Pigoligoarrays [19]. In Table 1 are
listed the PRRS resistance/susceptibility phenotypic
traits currently being tested as well as those that could
be collected with additional tests for deeper phenotypic
information if additional funding becomes available.
This continued phenotyping is possible because of the
extensive PHGC planning, detailed sample inventory at
KSU and BARC, and coordinated PHGC database.
Genomic DNA samples from all trial 1-6 PHGC pigs
have already been prepared and genotyped with the Por-
cine SNP60 SNPchip; a grant submission for the last
genotypes and RNA-seq analyses is under review. Gen-
ome-wide association studies (GWAS) are now under-
way to identify alleles and chromosomal regions that are
associated with anti-PRRSV infection responses. Overall,
the PHGC project will enable researchers to verify
important genotypes and phenotypes that predict resis-
tance/susceptibility to PRRSV infection.
Conclusion
The expected outcomes of the PRRS Host Genetics
Consortium are to: 1) Define genomic regions, SNP
alleles, or candidate genes [and source pig genetics]
which are correlated with PRRS resistance/susceptibility
quantitative trait loci (QTL); 2) Use these QTL to
develop selection procedures to lower the effects and
persistence of PRRSV virus in pigs; 3) Determine why
[some] pigs stay healthy despite PRRSV infection; 4)
Utilize information gained to help uncover unique
PRRSV resistance mechanisms and virus-host interac-
tions, thus highlighting alternate vaccine and therapeutic
Figure 1 Different anti-viral reponses associated with PRRS resistance/susceptibility. PHGC pigs exhibited different anti-PRRSV infection
responses as reflected in the serum viral levels after challenge. Circles, solid squares/long dashed lines – resistant pigs (1341, 1379, 1524, 1533);
Triangles/solid lines= susceptible pigs (1451, 1391); Squares/short dashed line = pigs with virus reactivation (1341, 1474).
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approaches; and 5) Identify pigs with improved resis-
tance not just to PRRS but to respiratory infections.
List of abbreviations used
Ab: Antibody; AUC: area under the curve; dpi: days post infection; GWAS:
genome-wide association studies; QTL: quantitative trait loci; PCV2: porcine
circovirus type 2; PRRSV: porcine reproductive and respiratory syndrome
virus; PHGC: PRRS Host Genetics Consortium.
Acknowledgements
The PHGC has funding from the US National Pork Board (NPB) (#07-233, #09-
208, #10-033 for PRRSV infection and #09-244 for FMIA analyses of serum
cytokines); PRRS CAP, USDA-NIFA Award #2008-55620-19132 for SNP
genotyping and GWAS analyses; and USDA NIFA AFRI Animal Genome
#2010-65205-20433 for gene expression analyses. In addition matching funds
have come from the USDA sponsored National Research Support Project 8
(NRSP-8) Swine Genome and Bioinformatics Coordination programs, from
several swine breeding companies, and from Hatch funds, Kansas State
University, Iowa State University, and USDA ARS project 1254-32000-088
support.
This article has been published as part of BMC Proceedings Volume 5
Supplement 4, 2011: Proceedings of the International Symposium on Animal
Genomics for Animal Health (AGAH 2010). The full contents of the
supplement are available online at http://www.biomedcentral.com/1753-
6561/5?issue=S4.
Author details
1Animal Parasitic Diseases Laboratory, BARC, ARS, USDA, Beltsville, MD 20705,
USA. 2Depts. Animal Science, and Fisheries and Wildlife, Michigan State Univ.,
East Lansing, MI 48824, USA. 3Dept. Animal Science, Center for Integrated
Animal Genomics, Iowa State Univ., Ames, IA 50011, USA. 4Dept. Diagnostic
Medicine and Pathobiology, College of Veterinary Medicine, Kansas State
Univ., Manhattan, KS 66506, USA.
Competing interests
The authors declare that they have no competing interests.
Published: 3 June 2011
Table 1 PRRS resistance/susceptibility traits for genome wide association studies (GWAS) and gene expression
pathway analyses
Sample Trait Current phenotypic information Potential phenotypic information
Blood serum
[collected at -6, 0, 4, 7, 10, 14, 21,
28, 35, 42 dpi]
Virus levels PRRS Viral qPCR
[4 dpi virus level, 7 dpi virus level, 0-19/21 dpi
virus level (= AUC, area under curve); 28 dpi virus
level]
PRRSV type 1 and 2
Virus sequence, especially during
reactivation
Presence of other viruses
Blood serum Antibody (Ab)
levels
IDEXX PRRSV Ab titer PRRSV Serum Neutralizing Abs
Decay of maternal anti-PCV2 Ab
Ab to other microbes
Blood serum Immune
Protein levels
Interleukin-8 (IL-8), Interferon-g (IFN-g)
Selected Luminex bead assays for 8 cytokines




(ABI Tempus tubes for RNA




Microarray (Pigoligoarray) based gene expression
QPCR for selected gene expression
Identification of “classifier genes” for PRRS
resistance
next generation sequencing analyses (RNA-
seq)
Alternate splicing events
Bioinformatic analysis of virus/host
correlated gene expression
Identify eQTL
Growing pig [during infection] Weight gain
(kg)
Weight gain [Overall 0-42 dpi; Weight gain at
peak virus replication]
New trials with growth to market weight
and extensive growth and pork quality
analyses





More Targeted SNPs, e.g., specific regions
or candidate genes
More extensive GWAS analyses including
eQTL and Ref-seq data
Tonsils [at 42 dpi] Mucosal
tissue; virus
reservoir
None PRRSV levels at 42 dpi - PRRSV persistence
Gene expression with persistent virus
Oral fluids
[pen samples]
Virus levels PRRSV levels PRRSV type 1 and 2
Virus sequence, especially during
reactivation
Presence of other viruses
Oral fluids Antibody (Ab)
levels
IDEXX PRRSV Ab titer PRRSV Serum Neutralizing Abs
Decay of maternal anti-PCV2 Ab
Ab to other microbes




Selected Luminex bead assay for cytokines More Luminex bead assays for multiple
cytokines, chemokines
Broad proteomic analyses
Sample usage plans for current phenotypic information and projected deeper phenotypic data possible with additional tests and funding.
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